Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 564

ALS amyotrophic lateral sclerosis

Journalist Moshe Nussbaum attends a ceremony at the Israel Police headquarters in Jerusalem on September 5, 2018. (Yonatan Sindel/Flash90)
January 8, 2025, 3:05 pm
AI helps veteran Israeli TV reporter return to the air after disease took his voice
Channel 12’s Moshe Nussbaum was diagnosed with ALS two years ago, which made him unable to speak clearly and seemingly ended his decades-long career; now he is making a comeback
By Melanie Lidman
Dr. Ariel Tankus conducts an experiment with a patient, who, his mouth closed, imagines saying a syllable, and the laptop 'says' it for him. (Courtesy, Tel Aviv University)
July 31, 2024, 9:54 am
Using AI, Tel Aviv University researcher hopes to turn patients’ thoughts into speech
Dr. Ariel Tankus says brain-computer interface could help paralyzed people communicate via the brain’s electron signals, offering optimism for those who lose speech capability
By Diana Bletter
An EyeControl device being applied to a patient. (Courtesy of EyeControl)
January 1, 2024, 6:07 pm
Israeli med tech company’s innovative headset could reduce delirium in ICU patients
EyeControl shifts focus in hopes of diminishing mental distress experienced by war wounded and other seriously ill individuals who are sedated and intubated
By Renee Ghert-Zand
A US Food and Drug Administration building is seen behind FDA logos at a bus stop on the agency's campus in Silver Spring, Maryland, on August 2, 2018. (Jacquelyn Martin/AP)
September 28, 2023, 8:45 am
FDA advisers vote against Israeli experimental ALS treatment pushed by patients
Health advisers overwhelmingly indicate Brainstorm’s stem cell-based approach has not been shown effective for patients with the fatal muscle-wasting disease
By MATTHEW PERRONE
Ayelet Shaked (L) and Idit Silman (R) at the Knesset on March 10, 2022 (Olivier Fitoussi/Flash90)
April 7, 2022, 1:35 pm
Daily Briefing April 7 – Anatomy of a breakup: What made Silman leave the coalition
Zman Yisrael editor Biranit Goren finds answers in the days before coalition whip Idit Silman’s dramatic resignation; health reporter Nathan Jeffay offers optimistic headlines
By ToI Staff
Ady Barkan, a high-profile health care activist who suffers from amyotrophic lateral sclerosis, testifies before the House Rules Committee on Capitol Hill in Washington, Tuesday, April 30, 2019. (AP/J. Scott Applewhite)
December 15, 2021, 12:54 am
Tel Aviv University breakthrough touted as key to reversing ALS
Israeli researchers say they used experimental molecule to break down protein whose buildup can cause the debilitating condition, also known as Lou Gehrig’s Disease
By ToI Staff
One of the best-known people to suffer from ALS was the late Professor Stephen Hawking. (Photo by Joel Ryan/Invision/AP)
November 2, 2021, 10:55 am
Israeli drug that slowed Alzheimer’s, ALS in mice gets funding to start trials
Molecules ‘amazing’ in delaying onset and progression of the conditions in mice, says researcher; if they’re 10% as effective in humans they’ll become a ‘very good drug’
By Nathan Jeffay
Jenni Kleinman Berebitsky with her husband, Jeff, and their son, Philip, as a baby. (From the film 'Grateful')
November 6, 2019, 11:44 pm
In film, recently deceased Jewish naturopath says ALS actually ‘saved her life’
In a short documentary screening November 7, wife, mom and triathlete Jenni Kleinman Berebitsky sends a message of vital hope as she turned an 18-month prognosis into 10 years
By Rich Tenorio
Prof. Boaz Lerner of Ben-Gurion University of the Negev has developed an AI-based software to monitor and predict the progression of neurodegenerative diseases. (Dani Machlis)
February 25, 2019, 12:28 pm
Israeli researchers develop AI-based software to track progression of ALS
Software will later be adapted to other neurodegenerative diseases, Ben-Gurion University technology transfer arm says; BGN Tech seeks partner to further develop the technology
By Shoshanna Solomon
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.